Phuong Khanh Morrow is Chief Medical Officer of CRISPR Therapeutics AG.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Oct 23 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 44.31 | 16,667 | 738.51 k | 16,667 |
24 May 23 | CRSP CRISPR Therapeutics | Common Shares | Payment of exercise | Dispose F | No | No | 65.91 | 2,527 | 166.55 k | 4,411 |
23 May 23 | CRSP CRISPR Therapeutics | Common Shares | Option exercise | Acquire M | No | No | 0 | 6,938 | 0.00 | 6,938 |
23 May 23 | CRSP CRISPR Therapeutics | RSU Common Shares | Option exercise | Acquire M | No | No | 0 | 6,938 | 0.00 | 20,812 |
10 Mar 23 | CRSP CRISPR Therapeutics | RSU Common Shares | Grant | Acquire A | No | No | 0 | 22,000 | 0.00 | 22,000 |
10 Mar 23 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 43.22 | 44,620 | 1.93 mm | 44,620 |